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SUMMARY: The cellular actions of nerve growth factor (NGF) involve regulation of protein 
phosphorylation. In PC- 12 pheochromocytoma cells, exposure of [ lzI]NGF followed by 
crosslinking indicates that the ligand binds to two discreet receptors, the previously described 75 
kd protein, as well as the trk proto-oncogene product ppl4oC- rrk Competition experiments reveal 
that of the two, ppl4CV’k binds to NGF with higher affinity. Following exposure to NGF, 
p~l4oC-~~~ undergoes a rapid autophosphorylation on tyrosine residues, and concomitantly 
phosphorylates and associates with phospholipase Cyl (PLCyl), through interaction with its src 
homology domains. The binding of NGF to p~l4oc-‘~k with high affinity, the NGF-dependent 
activation of its tyrosine kinase activity and the specific association with the effector molecule, 
PLCyl, suggests that this is the biologically relevant signaling receptor for NGF. a 1991 Academic 
Press, Inc. 
Although the mechanisms by which nerve growth factor (NGF) supports the survival and 
differentiation of sympathetic and sensory neurons remain elusive, changes in protein 
phosphorylation play an important role in the cellular actions of the growth factor. NGF increases 
the phosphoxylation of several cellular proteins (l-3), and is known to stimulate the activities of 
several serine/threonine kinases, including protein kinase C (4,5), MAP kinase (6,7), ribosomal 
S6 kinase (8), and others (9-13). Recent evidence suggests that one of the earliest responses to 
NGF is the stimulation of a protein tyrosine kinase (14), which may initiate the subsequent serine 
phosphorylation events (15). The cloning of a cDNA encoding a 75 kd NGF receptor predicted a 
protein with a relatively short cytoplasmic domain lacking a consensus tyrosine kinase sequence 
(16). Recent evidence indicates that the rrk prom-oncogene product (a member of the tyrosine 
kinase receptor family) also binds NGF (17) and that activation of the tyrosine kinase activity of rrk 
by NGF plays a significant role in NGF-dependent signal transduction. In this report, we have 
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Research Division,2800 Plymouth Paad, Ann Arbor, MI 48105. 
Abbreviations: PLCyl, phospholipase Cyl; GAP, GTPase-activating protein of rus; NGF, nerve 
growth factor, EGF, epidermal growth factor, SH, src homology. 
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examined the interaction of pp 140C-lrk with the potential effector proteins PLQl and the GTPase 
activating protein of r-as (GAP). 
MATERIALS AND METHODS 
Immunoprecipitation of crosslinked NGF-receptor complexes. 
PC-12 cells were harvested, pelleted, and resuspended in ice-cold binding buffer (137 mM NaCl, 
4.7 mM KCl, 2.5 mM CaC12, 1.2 mM KH$Q [ pH 7.41, 1.2 mM MgS04, 1 mg/ml glucose, 1 
mg/ml BSA, 10 mM HEPES [PHI 7.0), containing 1 mM phenylmethlsulfonyl flouride (PMSF) to 
a cell concentration of 1 X lo6 cells per ml. [ lBI]NGF (Amersham) was added at a concentration 
of 1 nM, and the cells were incubated on ice for 2 hr. Disuccinimidyl suberate (DSS) in 
dimethylsulfoxide was added at a final concentration of 150 pM, and further incubated for 30 min 
at room temperature.. Unreacted reagents were quenched by washing the cells twice in 10 mM 
Tris-saline @H 7.4). Cells were lysed in 500 pl of HY buffer, consisting of 50 mM HEPES pH 
7.5,150 mM NaCl, 10% glycerol, 1% Triton-X 100,1.5 mM MgC12,l mM EGTA, 10 mM 
sodium pyrophosphate, 100 ~JM sodium orthovanadate, 100 mM NaF, 30 mM p-nitrophenol 
phosphate, 10 us/ml leupeptin, and 1 mM PMSF according to Margolis et. al. (18). Lysates were 
centrifuged for 10 min at 10,000 x g and supematants incubated for 60 min with the indicated 
antisera Protein A-Sepharose beads were added for 30 min with mixing and immune complexes 
bound to the beads were washed three times with 1 ml of HY buffer. Immune complexes were 
solubilized in 25 pl of Laemmli sample buffer and loaded on 8% SDS gels (19). The dried gels 
were exposed to Kodak XAR film. 
Anti-phosphotyrosine Immunoblots. PC-12 cells, NR18 cells, n-k-transformed and control 
NlH3T3 cells (20) were grown in 150 mm dishes. Prior to hormonal treatment, the medium was 
replaced with serum-free medium and incubated for 1 hr. 10 nM NGF or 10 nM EGF were 
directly added to the medium and incubated for 1 min at 37°C. Cells were washed twice with 12 
ml ice-cold PBS and lysed in 1 ml HY buffer. Lysates were centrifuged at 10,000 x g for 10 min. 
Supematants were incubated for 1 hr with the anti-r& antiserum (21) or anti-PLCyl antiserum 
(22). Following the incubation, protein A-Sepharose beads were added for 30 min with mixing, 
and immune complexes bound to the beads were washed three times with 1 ml of HY buffer. 
Immune complexes were solubilized in 25 d of Laemmli sample buffer and loaded on 8% SDS 
gels. Transfer to nitrocellulose paper, immunoblotting with anti-phosphotyrosine antiserum and 
washing were performed as described (21). For blotting of tyrosine phosphorylated proteins 
binding to bacterially expressed SH domains of PLC$ and GAP, supematants were incubated for 
90 min with protein A-Sepharose beads to which immune complexes of anti-trpE-trpE-PLCyl or 
anti-trpE-trpE-GAP fusion proteins had been bound. The trpE-PLCrl fusion protein encompassed 
residues 545 to 95 1 of bovine PLCrl including both SH2 and SH3 domains of PLQl. The trpE- 
GAP fusion protein contained residues 117 to 444 of bovine GAP also encompassing both the 
SH2 and the SH3 domains of GAP. The beads were washed 3 times with 1 ml of HY buffer and 
samples resolved on 8% SDS gels. Immunoblotting with anti-phosphotyrosine antiserum was 
performed as described above. 
RESULTS AND DISCUSSION 
To substantiate that ppl4oC-trk was itself a receptor for NGF, PC- 12 cells were exposed to 
[t2sI]NGF (Fig. 1A). After a 2 hr incubation, NGF was crosslinked using disuccinimidyl 
suberate (DSS) (23). Lysates were absorbed with preimmune serum, antiserum against the 75 kd 
NGF receptor, antiserum against the conserved cytoplasmic domain of the rrk oncogene, or a 
fusion protein containing the src homology (SH) domain of PLQl fused to a bacterial trpE protein 
(24). Immunoprecipitation of the [ lzI]NGF crosslinked cells with anti-75 kd antiserum yielded a 
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F&J Immunoprecipitation of crosslinked NGF-receptor complexes. 
A) Lysates from [lZI]NGF-labeled and DSS-crosslinked PC-12 cells were precipitated with the 
indicated antisera. Lane 1: no antiserum. Lane 2: preimmune rabbit serum. Lane 3: rabbit anti- 
NGF receptor (7.5 kd) serum which was raised by immunizing rabbits with a trpE-NGF receptor 
bacterial fusion protein containing residues 260 to 399 of human NGF receptor (34). Lane 4: 
rabbit anti-& serum (21). Lane 5: immune complex of anti-trpE-trpE-PLCyl fusion protein 
which encompassed residues 545 to 951 of bovine PLCyl including both SH2 and SH3 domains 
of PLCvl. In (B) unlabeled NGF at concentrations of 1 nM to 1 uM was added to cells for 5 min 
before the initial 2 hr binding reaction of [WJNGF. Lysates from [tzI]NGF-labeled and DSS- 
crosslinked PC-12 cells were immunoprecipitated with rabbit anti-NGF receptor (75 kd) serum and 
rabbit anti-trk serum, as indicated. 
doublet with Mrs of approximately 80 and 95 k, but no other bands. Precipitation with ant&k 
antiserum, or with the PLCyl fusion protein revealed a single labeled band with Mr of 
approximately 160 kd. The 75 kd protein was not detected in these immunoprecipitates. These 
data suggest hat NGF binds to two discreet species of proteins in PC- 12 cells, and that one of 
these, pp 14OC-trk, binds to the SH regions of PLCyl. 
To compare the relative affinities of binding of these two proteins, cells were exposed to 
[ 1251]NGF in the presence of increasing concentrations of unlabeled NGF, followed by 
crosslinking and immunoprecipitation (Fig. 1B). Concentrations of 10-100 nM NGF were 
required to displace [t251]NGF from the 75 kd protein. In contrast, binding of [t251]NGF to 
p~l4oC-~‘~ was displaced with I-10 nM unlabeled NGF. While these results do not represent 
equilibrium binding experiments, and thus do not yield meaningful dissociation constants, they 
strongly suggest hat the binding of NGF to pp140C-frk is by at least an order of magnitude, of 
higher aftinity than the binding to ~75. 
A receptor is defined by its ability to transmit a relevant signal in the cell. PC-12 cells or 
PC- 12 mutant cells (NR18) that do not respond to NGF (20) were exposed to NGF, lysed and 
subject to itnmunoprecipitation with the anti& antiserum (Fig. 2A). Tyrosine phosphotylation 
was detected by SDS PAGE followed by immunoblotting (22). In confirmation of a recent report 
(17), NGF stimulated the tyrosine phosphotylation of pp140c-rrk in the responding PC-12 cells, 
but not in the nonresponding mutant cell line, whereas epidermal growth factor (EGF) had no 
effect (not shown). 
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Fig. 2.NGF induces the tyrosine phosphorylation of pplJOC-frk and its subsequent 
interaction with the PLCyl SH region. 
PC-12 cells, NR18 cells, rrk-transformed and control NM3T3 cells were grown in 150 mm 
dishes. 10 nM NGF or 10 nM EGF were directly added to the medium and incubated for 1 min at 
37’C. Lysates were immunoprecipitated with anti& antiserum (A) and anti-PLCyl antiserum (B) 
before analysis of immunoblotting with anti-phosphotyrosine antiserum as described. TrpE- 
PLCyt (C) and TrpE-GAP (D) fusion proteins immobilized with anti-TrpE antibodies were mixed 
with lysates and analyzed for associated proteins by antiphosphotyrosine immunoblotting. 
Following autophosphorylation on tyrosine residues, many receptors bind to signaling 
proteins that contain SH2 domains (22,24-26). NGF has been reported to stimulate the tyrosine 
phosphorylation of PLCyl (which contains 2 SH2 regions) (24), and we have recently observed 
(21) that the p70 rrk oncogene product binds specifically to the SH domain of PLC?yl. To 
determine whether NGF stimulated the association of ppl4oc-Rk with PLCyl, we precipitated cells 
treated with or without NGF with anti-PLCyl antiserum (Fig. 2B). In NGF treated cells, two 
tyrosine phosphorylated proteins were detected in these immunoprecipitates, the 148 kd PLCyl 
and the 140 kd trk proto-oncogene product. We also examined the effect of NGF on the binding 
of ppl4oC-trk to immobilized fusion proteins containing the SH2 domains of PLCyl (Fig. 2C) or 
GAP (Fig. 2D). As a positive control, EGF was shown to stimulate the association of its tyrosine 
phosphorylated receptor with both PLCyl and GAP in 3T3 and PC-12 cells. The constitutively 
activated p70 trk oncogene product from rrk transfected 3T3 cells associated with the PLQl fusion 
protein. NGF stimulated the association of p~l4oC-‘~k with the PLql fusion protein in PC-l 2 
cells, but not in the unresponsive NR18 cells. While EGF treatment of 3T3 or PC-12 cells caused 
the association of the tyrosine phosphorylated EGF receptor with an immobilized GAP fusion 
protein (Fig. 2C), exposure of cells to NGF was without effect. Low levels of p7O@k bound to 
the GAP fusion protein (21). Thus, the effect of NGF on the binding of ppl4W@k to signalling 
proteins appears to be specific for the SH domain of PLCyl . 
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Fig. 3.Kinetics of the NGF-induced binding of tyrosine phosphorylated ppl4W+k 
to the PLCyl SH domains in PC-12 cells. 
In (A), the time course of the binding of tyrosine phosphorylated ppl4W-rk to the trpE-PLCrt 
fusion proteins was evaluated. Cells were treated with 10 nM NGF for the indicated times at 37’C. 
In (B), the dose response of the ppl4W~~&pE-PLC~t interaction was evaluated. Cells were 
treated with indicated concentrations of NGF for 1 mm at 37’C. In both experiments, 
immunoblotting with anti-phosphotyrosine antiserum was Performed as described 
The time course of the NGF-dependent association of ppl4oC+k with the PLC?yl fusion 
protein was evaluated (Fig. 3A). Addition to PC-12 cells of 10 nM NGF caused the maximal 
association of ppl4oC-rrk with the fusion protein within 1 min of exposure. The binding rapidly 
declined thereafter, and was barely detectable after 10 minutes. The apparent reversal of this effect 
was even faster than the deactivation of MAP kinase (6,7) or pp40/42 tymsine phosphorylation 
(15), suggesting that autophosphorylation and association of ppl4Wpk with PLCyl are likely to 
be closely regulated events. The dose dependence of this response was also evaluated (Fig. 3B). 
Increasing concentrations of NGF were added to PC- 12 cells for 1 mitt, followed by lysis and 
evaluation of association of tyrosine phosphorylated ppl4OC-@k to the PLCyl fusion protein, as 
described above. ppl4OC-frk-PLCyl binding was observed with as little as 1 nM NGF, and was 
dose dependent up to 100 nM. 
These results strongly suggest that p~l4OC-‘~~ is the important receptor for NGF. This 
protein meets all the criteria for a hormone receptor; it exhibits saturable binding with 
physiologically relevant concentrations of the ligand and mediates an important biological 
response, tyrosine phosphorylation and interaction with a signalling protein that is thought to be 
involved in receptor function. The physical separation and the large difference in apparent affinity 
for the interaction of NGF with pp140C-lrk and the 75 kd protein raise questions about the roles of 
these two proteins in signal transduction for the growth factor. It has been suggested that these 
proteins together produce a high affinity binding phenotype that is responsible for insuring 
responsiveness to physiological levels of the hormone (27-29). However, in addition to the 
differences in affinities for NGF, separate immunoprecipitations from PC-12 cells that clearly 
express both binding proteins revealed no evidence for their coprecipitation. Moreover, NGF 
induces the association of only pp 14oC-‘rk but not ~75 with PLCyl . In this regard, a recent report 
(30) indicates that only the high affinity binding site is necessary for the biological activity of 
NGF. In fact, expression of p~l4oC-*~k in Xenopus oocytes produced a cell in which seminal 
vesicle breakdown and cdc2 kinase activation was stimulated by NGF (31). Taken together, these 
data imply that ppl4W@k and ~75 may exhibit distinct but related functions. Recent studies (6,7) 
on the stimulation of MAP kinase activity by NGF indicate that both serlne&reonine and tyrosine 
phosphorylation events are required for activation of the enzyme. Perhaps both proteins play a 
separate but important role in signaling. 
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What is the significance of the ppl4oc-wk-PLCyl interaction? Although PLCyl undergoes 
tyrosine phosphorylation in response to NGF (32, Fig. 2), we have failed to demonstrate an effect 
of the hormone on inositol lipid hydrolysis or calcium mobilization, although there is 
diacylglycerol production and protein kinase C activation (4,533). Although the lack of a 
polyphosphoinositide turnover response to NGF may be due to other abnormalities peculiar to the 
PC-12 tumor cell line, an interesting possibility is that the SH domain of PLql, or another 
protein, plays a separate regulatory role for pp140C-“k, perhaps modulating the interaction of this 
receptor with other signalling proteins, or tyrosine phosphatases. The likelihood of these and other 
possibilities requires further investigation. 
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